| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.16B | 69.40B | 62.50B | 51.42B | 58.39B | 51.73B |
| Gross Profit | 28.54B | 30.03B | 26.34B | 21.22B | 26.34B | 23.53B |
| EBITDA | 14.47B | 16.22B | 13.80B | 10.31B | 14.97B | 13.72B |
| Net Income | 9.21B | 9.06B | 9.43B | 6.50B | 10.59B | 9.16B |
Balance Sheet | ||||||
| Total Assets | 100.09B | 121.30B | 90.91B | 84.14B | 80.10B | 76.32B |
| Cash, Cash Equivalents and Short-Term Investments | 27.02B | 31.35B | 27.86B | 34.93B | 36.24B | 36.56B |
| Total Debt | 10.00B | 17.23B | 494.00M | 291.00M | 352.00M | 262.00M |
| Total Liabilities | 23.20B | 36.58B | 14.01B | 11.57B | 11.09B | 13.35B |
| Stockholders Equity | 76.09B | 83.87B | 76.12B | 72.58B | 69.01B | 62.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.66B | 413.00M | 3.77B | 5.63B | 7.74B |
| Operating Cash Flow | 0.00 | 12.60B | 12.99B | 7.45B | 7.38B | 9.30B |
| Investing Cash Flow | 0.00 | -20.15B | -15.87B | -5.31B | -822.00M | -1.10B |
| Financing Cash Flow | 0.00 | 12.18B | -5.64B | -5.64B | -6.14B | -3.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥530.84B | 20.39 | ― | 1.02% | 32.81% | 59.74% | |
73 Outperform | ¥239.40B | 21.97 | ― | 3.09% | 11.04% | -3.91% | |
72 Outperform | ¥98.29B | 12.23 | ― | 1.72% | 23.24% | 55.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥443.11B | 19.76 | 5.77% | 3.28% | 5.30% | -4.93% | |
61 Neutral | ¥195.07B | 36.24 | 10.10% | 1.00% | 1.66% | -43.45% | |
50 Neutral | ¥128.47B | -7.98 | ― | 2.45% | 1.60% | -74.21% |